Case Report: Entamoeba Histolytica and Candida Impair Artemisinin-Based Combination Therapy Effect in Malaria Patient

Simple item page
dc.contributor.authorMosab Nouraldein Mohammed Hamad
dc.date.accessioned2026-09-12T22:06:41Z
dc.date.issued2023-12-28
dc.description.abstractMalaria is an endemic disease in Sudan, and the emergence of antimalarial drugs resistance represent a serious problem affecting the Sudanese population. Acidity reduces absorption of antimalarial drugs and allows for malaria parasites to survive and multiply. Enteric pathogens such as Entamoeba histolytica, candida and Helicobacter pylori may support the growth of Plasmodium falciparum, through inhibition of the absorption of antimalarial agent, such as artemisinin-based combination therapy (ACT)
dc.identifier.citationMosab Nouraldein Mohammed Hamad (2023). Case Report: Entamoeba Histolytica and Candida Impair Artemisinin-Based Combination Therapy Effect in Malaria Patient. SAR J Pathol Microbiol, 4(6), 93-94.
dc.identifier.otherDOI: 10.36346/sarjpm.2023.v04i06.008
dc.identifier.urihttps://dspace.eaeu.edu.sd/handle/123456789/1079
dc.language.isoen
dc.publisherSAR publisher
dc.titleCase Report: Entamoeba Histolytica and Candida Impair Artemisinin-Based Combination Therapy Effect in Malaria Patient
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
SARJPM_46_93-94.pdf
Size:
121.2 KB
Format:
Adobe Portable Document Format
Download

Collections

open access articles